AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LOSARTAN POTASSIUM & HYDROCHLOROTHIAZIDE
23 registrations across 7 African markets— 20 active
Markets with LOSARTAN POTASSIUM & HYDROCHLOROTHIAZIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Synermed Losartan Potassium 50 mg and Hydrochlorothiazide 12.5 mg Tablets_ Tablet | 🇳🇬Nigeria | Synermed Nig Ltd | active | Aug 2030 |
| COLOSAR-DENK 50/12.5 FILM COATED TABLETS | 🇷🇼Rwanda | DENK PHARMA GmbH & Co. KG | active | May 2030 |
| COLOSAR-DENK 100/12.5 TABLETS | 🇬🇭Ghana | — | active | May 2030 |
| COLOSAR-DENK 100/12.5 TABLETS | 🇬🇭Ghana | — | active | May 2030 |
| Losa-H Tablets Tablet Uncoated | 🇿🇲Zambia | Lincoln Pharmaceuticals Limited | active | Apr 2030 |
| Losa-H Tablets Tablet Uncoated | 🇿🇲Zambia | Lincoln Pharmaceuticals Limited | active | Apr 2030 |
| LOSARZED-H Tablets | 🇷🇼Rwanda | Zota Healthcare Ltd | active | Oct 2029 |
| Lorzide Tablet Tablet | 🇳🇬Nigeria | Unosource Pharma Nigeria Limited | active | Oct 2028 |
| Angizaar H Tablets** Tablet | 🇳🇬Nigeria | Micro Nova Pharmaceuticals Ind Ltd | active | Jul 2028 |
| Angilock Plus 100/12.5 Tablet Tablet | 🇰🇪Kenya | SQUARE Pharmaceuticals Ltd. | active | Sept 2027 |
| Artazide Tablet (duplicate) Tablet | 🇳🇬Nigeria | Preferred Drugs Nigeria Limited | active | Aug 2026 |
| CoLosar-Denk 50/12.5 mg Tablets** Tablet | 🇳🇬Nigeria | Assene-Laborex Limited | active | Aug 2026 |
| Presartan H50 Tablets Tablet | 🇳🇬Nigeria | IPCA Pharma Nigeria Limited | active | Aug 2026 |
| LOSACAR-H 50/12.5 Tablets | 🇷🇼Rwanda | CADILA HEALTHCARE LTD | expired | Jun 2026 |
| LOSACAR-H 100/25 Tablets | 🇷🇼Rwanda | CADILA HEALTHCARE LTD | expired | Jun 2026 |
| Losakind-50 H Tablets Tablet | 🇳🇬Nigeria | Phillips Pharmaceuticals (Nigeria) Limited | active | Jan 2026 |
| Rista H Tablet 100/25 Tablet | 🇳🇬Nigeria | Dony-Triumph and Company Nigeria Limited | active | Dec 2025 |
| Rista H Tablet 50/12.5 Tablet | 🇳🇬Nigeria | Dony-Triumph and Company Nigeria Limited | active | Dec 2025 |
| Nusar-H Tablets (null smpc) Tablet | 🇳🇬Nigeria | Emcure Nigeria Limited | active | Dec 2025 |
| Asartan-H Tablets Tablet | 🇳🇬Nigeria | Astranad Pharmaceuticals and Chemical Company Limited | active | Nov 2025 |
| Losatrust-H Tablets Tablet | 🇳🇬Nigeria | Al-Tinez Pharmaceuticals Limited | active | Nov 2025 |
| PRESARTAN_H_50 50MG TABLETS TABLETS | 🇲🇼Malawi | — | expired | Jun 2010 |
| LOSARMAX comprimé / 50 mg /12,5 mg | 🇸🇳Senegal | DPA LES BERGES DU LAC | active | — |
LOSARTAN POTASSIUM & HYDROCHLOROTHIAZIDE in Africa — Regulatory Overview
LOSARTAN POTASSIUM & HYDROCHLOROTHIAZIDE is registered across 7 African markets with 23 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Rwanda, Ghana, Zambia and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 23 registrations, 20 (87%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.